A Phase 4 Study of Nusinersen (BIIB058) Among Patients With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec
Details
Age
Child
Locations
Childrens Hospital Colorado
Principal Investigator
Julie Parsons
Study ID
Protocol Number: 20-2793
More information available at ClinicalTrials.gov: NCT04488133
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers